Vir Biotechnology IncNASDAQ:VIR
- LAST PRICE7.8000
- TODAY'S CHANGE (%)-0.1300 (-1.6393%)
- Bid / Lots7.6000/ 3
- Ask / Lots8.3500/ 2
- Open / Previous Close7.9400 / 7.9300
- Day Range
- 52 Week Range
- Volume844,804
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VIR |
|---|---|---|
| 09:32 ET | 6365 | 7.935 |
| 09:34 ET | 4805 | 7.94 |
| 09:36 ET | 323 | 7.955 |
| 09:38 ET | 500 | 7.98 |
| 09:39 ET | 100 | 7.96 |
| 09:41 ET | 100 | 7.98 |
| 09:43 ET | 5200 | 7.98 |
| 09:45 ET | 617 | 7.98 |
| 09:50 ET | 100 | 8 |
| 09:52 ET | 7225 | 7.98 |
| 09:54 ET | 6634 | 8.005 |
| 09:56 ET | 2100 | 7.99 |
| 09:57 ET | 200 | 7.985 |
| 09:59 ET | 2165 | 8 |
| 10:01 ET | 712 | 7.965 |
| 10:06 ET | 312 | 7.94 |
| 10:10 ET | 100 | 7.93 |
| 10:12 ET | 400 | 7.94 |
| 10:14 ET | 580 | 7.93 |
| 10:15 ET | 912 | 7.92 |
| 10:17 ET | 1567 | 7.93 |
| 10:21 ET | 200 | 7.93 |
| 10:26 ET | 100 | 7.93 |
| 10:28 ET | 100 | 7.92 |
| 10:30 ET | 700 | 7.93 |
| 10:32 ET | 4052 | 7.94 |
| 10:33 ET | 400 | 7.93 |
| 10:35 ET | 212 | 7.91 |
| 10:37 ET | 604 | 7.92 |
| 10:39 ET | 200 | 7.93 |
| 10:42 ET | 1404 | 7.93 |
| 10:48 ET | 100 | 7.95 |
| 10:50 ET | 2500 | 7.95 |
| 10:51 ET | 400 | 7.94 |
| 10:53 ET | 300 | 7.95 |
| 10:55 ET | 120 | 7.94 |
| 10:57 ET | 300 | 7.95 |
| 11:00 ET | 900 | 7.945 |
| 11:02 ET | 4856 | 7.9499 |
| 11:04 ET | 912 | 7.95 |
| 11:06 ET | 1200 | 7.94 |
| 11:08 ET | 600 | 7.96 |
| 11:11 ET | 1600 | 7.93 |
| 11:13 ET | 100 | 7.93 |
| 11:15 ET | 500 | 7.92 |
| 11:18 ET | 1895 | 7.905 |
| 11:22 ET | 760 | 7.9 |
| 11:24 ET | 1308 | 7.9 |
| 11:26 ET | 2087 | 7.909 |
| 11:27 ET | 746 | 7.9 |
| 11:29 ET | 2790 | 7.915 |
| 11:31 ET | 2251 | 7.9 |
| 11:36 ET | 1044 | 7.905 |
| 11:38 ET | 100 | 7.905 |
| 11:40 ET | 328 | 7.91 |
| 11:42 ET | 400 | 7.905 |
| 11:44 ET | 10971 | 7.9 |
| 11:45 ET | 100 | 7.9 |
| 11:47 ET | 1700 | 7.9 |
| 11:49 ET | 5103 | 7.88 |
| 11:51 ET | 1412 | 7.88 |
| 11:54 ET | 860 | 7.88 |
| 11:56 ET | 600 | 7.88 |
| 11:58 ET | 100 | 7.88 |
| 12:00 ET | 902 | 7.8612 |
| 12:02 ET | 500 | 7.855 |
| 12:03 ET | 400 | 7.86 |
| 12:05 ET | 5933 | 7.83 |
| 12:07 ET | 1230 | 7.86 |
| 12:09 ET | 200 | 7.86 |
| 12:12 ET | 400 | 7.87 |
| 12:14 ET | 300 | 7.87 |
| 12:16 ET | 100 | 7.87 |
| 12:18 ET | 800 | 7.865 |
| 12:20 ET | 374 | 7.86 |
| 12:21 ET | 380 | 7.8508 |
| 12:23 ET | 100 | 7.855 |
| 12:25 ET | 1014 | 7.85 |
| 12:32 ET | 700 | 7.841 |
| 12:34 ET | 500 | 7.83 |
| 12:36 ET | 100 | 7.83 |
| 12:38 ET | 200 | 7.835 |
| 12:39 ET | 1486 | 7.855 |
| 12:41 ET | 1870 | 7.84 |
| 12:43 ET | 200 | 7.84 |
| 12:45 ET | 100 | 7.835 |
| 12:48 ET | 1600 | 7.825 |
| 12:52 ET | 200 | 7.83 |
| 12:54 ET | 2313 | 7.815 |
| 12:56 ET | 700 | 7.83 |
| 12:57 ET | 100 | 7.835 |
| 12:59 ET | 400 | 7.825 |
| 01:01 ET | 200 | 7.82 |
| 01:03 ET | 1308 | 7.81 |
| 01:08 ET | 1800 | 7.805 |
| 01:10 ET | 216 | 7.8059 |
| 01:12 ET | 700 | 7.81 |
| 01:14 ET | 100 | 7.81 |
| 01:15 ET | 3814 | 7.83 |
| 01:17 ET | 200 | 7.82 |
| 01:21 ET | 100 | 7.83 |
| 01:24 ET | 908 | 7.8298 |
| 01:28 ET | 1309 | 7.84 |
| 01:30 ET | 922 | 7.84 |
| 01:32 ET | 100 | 7.85 |
| 01:33 ET | 2468 | 7.865 |
| 01:35 ET | 414 | 7.86 |
| 01:37 ET | 100 | 7.865 |
| 01:39 ET | 1907 | 7.86 |
| 01:44 ET | 156 | 7.855 |
| 01:46 ET | 100 | 7.855 |
| 01:48 ET | 725 | 7.865 |
| 01:51 ET | 600 | 7.8591 |
| 01:53 ET | 505 | 7.86 |
| 01:55 ET | 500 | 7.865 |
| 01:57 ET | 100 | 7.865 |
| 02:00 ET | 1935 | 7.88 |
| 02:02 ET | 22520 | 8.01 |
| 02:04 ET | 11736 | 8.03 |
| 02:06 ET | 59097 | 8 |
| 02:08 ET | 6760 | 7.995 |
| 02:09 ET | 3368 | 7.97 |
| 02:11 ET | 3200 | 7.99 |
| 02:13 ET | 4484 | 7.93 |
| 02:15 ET | 3446 | 8.02 |
| 02:18 ET | 4593 | 8 |
| 02:20 ET | 5340 | 8 |
| 02:22 ET | 25416 | 8.005 |
| 02:24 ET | 5043 | 7.99 |
| 02:26 ET | 200 | 8 |
| 02:27 ET | 8034 | 8 |
| 02:29 ET | 31433 | 8.015 |
| 02:31 ET | 14188 | 8.01 |
| 02:33 ET | 14348 | 8.08 |
| 02:36 ET | 2950 | 8.085 |
| 02:38 ET | 9494 | 8.055 |
| 02:40 ET | 6897 | 8.12 |
| 02:42 ET | 5851 | 8.11 |
| 02:44 ET | 2226 | 8.085 |
| 02:45 ET | 16542 | 8 |
| 02:47 ET | 4600 | 8.04 |
| 02:49 ET | 4411 | 8.03 |
| 02:51 ET | 700 | 8.0425 |
| 02:54 ET | 5449 | 8.055 |
| 02:56 ET | 1719 | 8.0625 |
| 02:58 ET | 5579 | 8.08 |
| 03:00 ET | 2300 | 8.02 |
| 03:02 ET | 5600 | 8.005 |
| 03:03 ET | 1574 | 7.94 |
| 03:05 ET | 2583 | 7.955 |
| 03:07 ET | 1300 | 7.88 |
| 03:09 ET | 600 | 7.875 |
| 03:12 ET | 100 | 7.865 |
| 03:14 ET | 2601 | 7.91 |
| 03:16 ET | 36722 | 7.94 |
| 03:18 ET | 4334 | 7.915 |
| 03:20 ET | 600 | 7.87 |
| 03:21 ET | 608 | 7.84 |
| 03:23 ET | 2326 | 7.85 |
| 03:25 ET | 772 | 7.86 |
| 03:27 ET | 2740 | 7.88 |
| 03:30 ET | 1500 | 7.92 |
| 03:32 ET | 926 | 7.92 |
| 03:34 ET | 1618 | 7.9 |
| 03:36 ET | 1217 | 7.87 |
| 03:38 ET | 2126 | 7.835 |
| 03:39 ET | 1842 | 7.86 |
| 03:41 ET | 1002 | 7.8309 |
| 03:43 ET | 2134 | 7.84 |
| 03:45 ET | 4483 | 7.81 |
| 03:48 ET | 7119 | 7.815 |
| 03:50 ET | 6120 | 7.815 |
| 03:52 ET | 1373 | 7.815 |
| 03:54 ET | 3543 | 7.8 |
| 03:56 ET | 5305 | 7.835 |
| 03:57 ET | 2352 | 7.815 |
| 03:59 ET | 105223 | 7.8 |
Sep 10, 2024
*DJ Vir Biotechnology Appoints Jason O'Byrne As Chief Financial Officer >VIR, from 8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:05AM ET on Tuesday Sep 10, 2024 by Dow JonesVir Biotechnology Appoints Jason O'Byrne as Chief Financial Officer, from 8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 9, 2024
Sep 4, 2024
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031, from 8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
Aug 22, 2024
Vir Biotechnology to Participate in the Morgan Stanley 22(nd) Annual Global Healthcare Conference, from 8:05AM ET on Thursday Aug 22, 2024 by Dow Jones
8:05AM ET on Thursday Aug 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vir Biotechnology Inc | 1.1B | -2.2x | --- |
Prothena Corporation PLC | 1.2B | -21.3x | --- |
Zymeworks Inc | 873.9M | -8.2x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -4.8x | --- |
Silence Therapeutics PLC | 847.0M | -14.3x | --- |
Silence Therapeutics PLC | 850.6M | -13.6x | --- |
Company Information
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Contact Information
- Headquarters
- 1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
- Phone
- 415-906-4324
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Vicki Sato
- Chief Executive Officer, Director
- Marianne De Backer
- Executive Vice President, Chief Technology Officer
- Ann Hanly
- Executive Vice President, Chief Scientific Officer
- Jennifer Towne
- Executive Vice President and Chief Business Officer
- Jeffrey Calcagno
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
|---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.47 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 13.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
